{
    "clinical_study": {
        "@rank": "85876", 
        "arm_group": {
            "arm_group_label": "Drug treatment", 
            "arm_group_type": "Experimental", 
            "description": "1,25-Dihydroxycholecalciferol 5 ug orally per day for 2 years"
        }, 
        "brief_summary": {
            "textblock": "Vitamin D in the diet undergoes changes in the liver and kidneys to several forms.  Patients\n      suffering from disorders with Vitamin D resistance are unable to absorb calcium from food.\n      Patients diagnosed with these disorders will be evaluated and treated with high doses of\n      another form of Vitamin D  (1,25-dihydroxyvitamin D3).  Patients will be monitored and\n      observed throughout the study to avoid experiencing side effects from the medication."
        }, 
        "brief_title": "Studies With 1,25-Dihydroxycholecalciferol", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "Patient has rickets (cild) or osteomalacia (adult) of bone", 
                        "title": "Group 1"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "6"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@lower_limit": "5", 
                                            "@upper_limit": "50", 
                                            "@value": "15"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Full Range", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "3"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "3"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "6"
                                        }
                                    }, 
                                    "sub_title": "United States"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "outcome_list": {
                "outcome": {
                    "description": "Normal calcium concentration 8.2-10.6 mg/dL", 
                    "group_list": {
                        "group": {
                            "@group_id": "O1", 
                            "description": "Patient has rickets (cild) or osteomalacia (adult) of bone", 
                            "title": "Group 1"
                        }
                    }, 
                    "measure_list": {
                        "measure": [
                            {
                                "category_list": {
                                    "category": {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "O1", 
                                                "@value": "6"
                                            }
                                        }
                                    }
                                }, 
                                "param": "Number", 
                                "title": "Number of Participants", 
                                "units": "participants"
                            }, 
                            {
                                "category_list": {
                                    "category": {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "O1", 
                                                "@lower_limit": "8", 
                                                "@upper_limit": "11", 
                                                "@value": "6"
                                            }
                                        }
                                    }
                                }, 
                                "description": "Normal calcium concentration 8.2-10.6 mg/dL", 
                                "param": "Number", 
                                "title": "Number of Participants With Normal Serum Calcium Concentrations", 
                                "units": "participants"
                            }
                        ]
                    }, 
                    "safety_issue": "No", 
                    "time_frame": "1 year average", 
                    "title": "Number of Participants With Normal Serum Calcium Concentrations", 
                    "type": "Primary"
                }
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "Patient has rickets (child) or osteomalacia (adult) of bone", 
                        "title": "Group 1"
                    }
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "6", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "1", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "5", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "email": "marxs@mail.nih.gov", 
                "name_or_title": "Stephen J. Marx, M.D./National Institute of Diabetes and Digestive and Kidney Diseases", 
                "organization": "NIH", 
                "phone": "3014965051"
            }
        }, 
        "completion_date": {
            "#text": "October 2009", 
            "@type": "Actual"
        }, 
        "condition": [
            "Hypocalcemia", 
            "Rickets"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypocalcemia", 
                "Rickets"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients with extreme resistance to 1,25-dihydroxyvitamin D will be evaluated and treated\n      with high doses of 1,25-dihydroxyvitamin D3.\n\n      Plan: In previously untreated patients the study will be divided into a control and one or\n      more treatment periods. During the control period, parathyroid status will be assessed by\n      parameters nos. 1& 2 (below). In previously treated patients maintenance vitamin D will be\n      gradually replaced with 1,25(OH)2D3. This will be accomplished by withdrawal of vitamin D\n      and institution of 1,25(OH)2D3 when the serum calcium shows a downward trend.\n\n      1,25(OH)2D3 as 0.25 or 0.5 ug capsules (though IND 20,889) or as a solution of I microgram\n      per ml will be administered orally.  In most cases, because of consideration of time and\n      expense, the cooperation of the patient's local physician will be enlisted. The following\n      will be monitored:\n\n        1. Serum calcium, phosphorus,alkaline phosphatase,creatinine at twice weekly intervals.\n           After a maintenance dose has been established, this will be decreased to a monthly, and\n           subsequently 3-6 monthly interval.\n\n        2. Urine calcium, phosphorus,creatinine and cAMP before therapy and, when appropriate,\n           during therapy.\n\n      The dose of 1,25(OH)2D3 will be 0.125 to 50.0 ug/day. Serum calcium will not be allowed to\n      rise above the normal range (2.0 -2.4 mM at NIH).  Should hypercalcemia occur, appropriate\n      treatment will be initiated and the drug dosage will be decreased."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  INCLUSION CRITERIA:\n\n        Patients with hereditary resistance to calcitrol."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "6", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 3, 1999", 
        "firstreceived_results_date": "November 12, 2010", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001151", 
            "org_study_id": "760081", 
            "secondary_id": "76-DK-0081"
        }, 
        "intervention": {
            "arm_group_label": "Drug treatment", 
            "description": "Usual doses of 1,25-dihydroycholecalciferol are 0.25-1 ug per day. All patients in this study received very high doses or 5-20 ug per day.", 
            "intervention_name": "1,25-Dihydroxycholecalciferol", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Calcitriol", 
                "Dihydroxycholecalciferols"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Calciferol", 
            "Hypocalcemia", 
            "Rickets"
        ], 
        "lastchanged_date": "November 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Institutes of Health Clinical Center, 9000 Rockville Pike"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Studies With 1,25-Dihydroxycholecalciferol", 
        "overall_official": {
            "affiliation": "NIDDK/NIH", 
            "last_name": "Stephen J Marx, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Normal calcium concentration 8.2-10.6 mg/dL", 
            "measure": "Number of Participants With Normal Serum Calcium Concentrations", 
            "safety_issue": "No", 
            "time_frame": "1 year average"
        }, 
        "reference": [
            {
                "PMID": "6893458", 
                "citation": "Marx SJ, Swart EG Jr, Hamstra AJ, DeLuca HF. Normal intrauterine development of the fetus of a woman receiving extraordinarily high doses of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab. 1980 Nov;51(5):1138-42."
            }, 
            {
                "PMID": "4357855", 
                "citation": "Fraser D, Kooh SW, Kind HP, Holick MF, Tanaka Y, DeLuca HF. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. N Engl J Med. 1973 Oct 18;289(16):817-22. No abstract available."
            }, 
            {
                "PMID": "233695", 
                "citation": "Marx SJ, Spiegel AM, Brown EM, Gardner DG, Downs RW Jr, Attie M, Hamstra AJ, DeLuca HF. A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab. 1978 Dec;47(6):1303-10."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001151"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National Institutes of Health Clinical Center (CC)", 
            "investigator_full_name": "Stephen Marx, M.D.", 
            "investigator_title": "Chief of the Metabolic Diseases Branch of NIDDK/NIH", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "March 1976", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013", 
        "why_stopped": "Terminated because of lack of drug supply"
    }, 
    "geocoordinates": {
        "National Institutes of Health Clinical Center, 9000 Rockville Pike": "38.985 -77.095"
    }
}